Cargando…
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study
BACKGROUND: Pancreatic adenocarcinoma is a high-mortality neoplasm with a documented 5-years-overall survival around 5%. In the last decades, a real breakthrough in the treatment of the disease has not been achieved. Here we propose a prospective, phase II, multicentre, single-arm study aiming to as...
Autores principales: | Vitolo, Viviana, Cobianchi, Lorenzo, Brugnatelli, Silvia, Barcellini, Amelia, Peloso, Andrea, Facoetti, Angelica, Vanoli, Alessandro, Delfanti, Sara, Preda, Lorenzo, Molinelli, Silvia, Klersy, Catherine, Fossati, Piero, Orecchia, Roberto, Valvo, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744648/ https://www.ncbi.nlm.nih.gov/pubmed/31521134 http://dx.doi.org/10.1186/s12885-019-6108-0 |
Ejemplares similares
-
Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
por: Barcellini, Amelia, et al.
Publicado: (2020) -
Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma
por: Cobianchi, Lorenzo, et al.
Publicado: (2016) -
Erratum to: Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma
por: Cobianchi, Lorenzo, et al.
Publicado: (2016) -
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy
por: Orlandi, Ester, et al.
Publicado: (2023) -
Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak?
por: Barcellini, Amelia, et al.
Publicado: (2020)